Schizophrenia Bulletin vol. 35 no. 2 pp. 443–457, 2009 doi:10.1093/schbul/sbn018 Advance Access publication on April 15, 2008 Antipsychotic Combinations vs Monotherapy…

1. Actionable Cancer Network ModelsAnd Open Medical Information Systems Stephen Friend MD PhDSage Bionetworks (Non-Profit Organization) Seattle/ Beijing/ AmsterdamDiscovery…

1. If the physicists do it, the software engineers do it, Why can’t we do it?:Networked Team Approaches among PPPUse of Bionetworks to build maps of disease: Moving beyond…

1. Why not use data intensive science to build models of diseaseCurrent Reward StructuresOrganizational Structures and ToolsSix Pilots 2. What  is  the  problem?    …

1. Dr Harshal Rajekar. HPB, GI and transplant Surgeon, Ruby Hall Clinic 2.  Intended to enhance the clinicians ability to determine whether a study done or new findings…

1. Adelaide Health Technology Assessment (AHTA)Monday, June 25, 2012HOW TO ASSESS PERSONALISED MEDICINESFOR REIMBURSEMENT DECISIONS?Developing a framework for AustraliaTracy…

Slide 1Statistical stuff happens Vioxx, placebo power and other wonders Slide 2 Slide 3 Slide 4 Slide 5 A few headlines Low fat diet breast cancer hope ( BBC May 2005 ) Breast…

Slide 1Beyond the Basics Jaleh Gholami MD,MPH, PhD candidate Beyond the Basics Jaleh Gholami MD,MPH, PhD candidate Slide 2 Accuracy of research The inferences made from results…

Slide 1 Slide 2 Are we using available evidence at the best? Nicola Magrini AIFA Spring Seminar 30 Marzo 2007 Slide 3 Contents of the presentation Are regulatory agencies…

Slide 1The Platinum Journal COME SCRIVERE UN LAVORO SCIENTIFICO 85° Congresso SIU - Venezia 2012 Review Article: how to summarize the evidence Slide 2 The Platinum Journal…